Human c-MYBPC3 RNA Targeted Therapy, Reversal of Hypertrophic Cardiomyopathy in the Zebrafish Model
Page 1 of 1
Human c-MYBPC3 RNA Targeted Therapy, Reversal of Hypertrophic Cardiomyopathy in the Zebrafish Model
Jon Moulton Mon Nov 21, 2016 2:29 pm
Yalcin H, Da’as SI, Mohammed IA, Nasrallah GK, Al Suwaidi J, Yacoub MH. Human c-MYBPC3 RNA Targeted Therapy, Reversal of Hypertrophic Cardiomyopathy in the Zebrafish Model. Qatar Foundation Annual Research Conference Proceedings 2016;HBPP2955 http://dx.doi.org/10.5339/qfarc.2016.HBPP2955.
Jon Moulton- Posts : 5721
Join date : 2010-03-12
Age : 62
Location : Philomath, Oregon, USA -
Similar topics» Human cardiomyopathy mutations induce myocyte hyperplasia and activate hypertrophic pathways during cardiogenesis in zebrafish
» Splicing-Directed Therapy in a New Mouse Model of Human Accelerated Aging
» Targeted Skipping of Human Dystrophin Exons in Transgenic Mouse Model Systemically for Antisense Drug Development
» In vivo natriuretic peptide reporter assay identifies chemical modifiers of hypertrophic cardiomyopathy signalling
» Reprofiling using a zebrafish melanoma model reveals drugs cooperating with targeted therapeutics
» Splicing-Directed Therapy in a New Mouse Model of Human Accelerated Aging
» Targeted Skipping of Human Dystrophin Exons in Transgenic Mouse Model Systemically for Antisense Drug Development
» In vivo natriuretic peptide reporter assay identifies chemical modifiers of hypertrophic cardiomyopathy signalling
» Reprofiling using a zebrafish melanoma model reveals drugs cooperating with targeted therapeutics
Page 1 of 1
Permissions in this forum:
You cannot reply to topics in this forum